CNO Financial Group, Inc. (CNO) Stock

CNO Financial Group, Inc. (CNO) is a Healthcare stock trading at $54.23 (as of 2026-08-24), with a market capitalization of $5.02B and a trailing P/E of 18.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

CNO Financial Group, Inc., through its subsidiaries, designs and administers insurance products including Medicare supplement and related supplemental health coverage, long-term care and life insurance, and annuities, and also offers Medicare Advantage plans. It distributes these products to individuals in the U.S. via multiple channels, and provides group and worksite sales to employer and other membership groups.

Understand CNO Financial Group, Inc.: how it makes money

CNO Financial Group sells and administers health insurance, annuities, and individual life insurance, including Medicare-related products, and it makes money primarily from insurance policy income and also from fee revenue.

The profit engine is its insurance business, where insurance policy income is the largest revenue line item, supported by smaller fee revenue from administering and servicing its insurance products and plans.

Business quality (Weak): Clear business model (insurance products generating insurance policy income, plus fee revenue), but the provided information lacks a full official segment breakdown and does not include gross margin or more detailed operating drivers.

Valuation: At 20× earnings, CNO trades 55% above the Insurance average (13×). Note: one-time items can distort reported P/E.

Bull case

  • Insurance policy income is the dominant revenue line item (0.67B): A large share of revenue comes directly from its core insurance products, which can help anchor earnings power if policy income remains stable.
  • Additional fee revenue (0.04B) provides some diversification within its revenue base: Fees can support results alongside policy income rather than relying on policy income alone.

Bear case

  • Revenue concentration in insurance policy income (0.67B) and limited fee revenue (0.04B): If outcomes tied to the underlying insured business change materially, there is less fee revenue to offset declines.
  • Limited transparency in the provided breakdown: With no clean official segment breakdown here and no gross margin data, it is harder to pinpoint which parts of the product set drive operating performance.
Valuation — source: SEC EDGAR (first-party)
Price$54.23
Market Cap$5.02B
P/E Ratio18.0
EV / EBITDA3.3
Price / Book1.94
Price / Sales1.08
DCF Value (model)$39.58
DCF Upside vs Price-27.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$4.49B
Net Margin5.1%
Revenue Growth (YoY)11.6%
EPS Growth (YoY)45.2%
Valuation vs Sector & Industry
Stock P/E18.0
Sector P/E (Healthcare)21.7
Industry P/E (Insurance)13.1
vs Sector-16.9%
vs Industry37.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($536.02M)
Institutional Holders Tracked10
Congressional Trades (recent)3
Company
SectorHealthcare
IndustryInsurance
CEOGary Chandru Bhojwani
Employees3,400
CountryUS
IPO Date2003-09-10

Related Companies (Insurance; 8 comparable insurers)

  • Unum Group (UNM)
  • Aflac Incorporated (AFL)
  • Principal Financial Group, Inc. (PFG)
  • F&G Annuities & Life, Inc. (FG)
  • Globe Life Inc. (GL)
  • Primerica, Inc. (PRI)
  • Jackson Financial Inc. (JXN)
  • Brighthouse Financial, Inc. (BHFAL)
CNO earnings history · CNO institutional & insider holders · CNO KPIs & operating metrics · CNO financials · CNO investor presentations & press releases · CNO SEC filings · CNO peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-24.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.